Anti-viral drug remdesivir reduces risk of hospitalization in high-risk COVID-19 patients by 87% when given early | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

Anti-viral drug remdesivir reduces risk of hospitalization in high-risk COVID-19 patients by 87% when given early

Remdesivir reduces the risk of hospitalization and medical visits due to COVID-19 in high-risk patients, new data suggest.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA